ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: health insurance

Biosimilars: Still Waiting for Promise to Materialize

Larry Beresford  |  January 17, 2018

During the 2017 ACR/ARHP Annual Meeting, advances in biosimilar treatments were abuzz. However, many speakers noted that the presence of biosimilars on the market has not yet resulted in greater access to treatment and lower drug pricing in the U.S…

Filed under:Biologics/DMARDsDrug UpdatesMeeting Reports Tagged with:2017 ACR/ARHP Annual MeetingACR/ARHP Annual MeetingBiologics & BiosimilarsBiosimilarsdrug pricingDrug Updatesinterchangeability

Meet Chris Adams, MD, the New Chair of the ACR’s Affiliate Society Council

Carol Patton  |  January 4, 2018

What initially strikes people about Christopher Adams, MD, FACP, FACR, is his passion for fairness. In 2015, he told readers of The Rheumatologist, “Patients often feel powerless to fight the system and advocate for themselves, and many of my patients felt they lacked a mechanism for addressing their concerns. That’s where we come in.” Dr….

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:ACR’s Affiliate Society CouncilChris Adamsincoming chair

Rheumatologist Deborah Desir Brings Advocacy, Fundraising to the Home Front

Gretchen Henkel  |  December 20, 2017

When former ACR President Joseph Flood, MD, tapped Deborah Dyett Desir, MD, to volunteer for an ACR committee, he might have assumed that her preference would be to serve on the Committee on Rheumatologic Care or its Insurance Subcommittee. After all, Dr. Desir is in private practice at the Arthritis and Osteoporosis Center PC in…

Filed under:Legislation & Advocacy Tagged with:Dr. Deborah Dyett DesirFundraising

The ACR Maintains Seat at the AMA Table, Achieves Successful Resolutions at HOD Meeting

Kelly Tyrrell  |  December 20, 2017

Together our voice is heard; our influence is alive. In 2017, ACR members heard the call of the Rheumatology Strong campaign and joined the American Medical Association (AMA) in force, ensuring the College maintains its representation in the country’s largest—and arguably most influential—physician society. “We surpassed our minimum 1,000-member goal by a margin and are hopeful…

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:AMA House of Delegates (HOD)American Medical Association (AMA)Consultation Codes and Private PayersPharmacy Benefit Managers and Prescription Drug AffordabilityResolution 225Resolution 810Resolution 819Rheumatology Strong! campaign

Long-Term Benefits, Risks of Biologic Disease-Modifying Anti-Rheumatic Drugs in Patients with RA

Nan Yang, PharmD, & Kurt Oelke, MD, on behalf of the ARHP Practice Committee  |  December 19, 2017

Two decades have passed since the first biologic disease-modifying anti-rheumatic drug (bDMARD) was approved. Studies on the long-term use of biologics in different disease states, such as for cardiovascular disease (CVD) and malignancy, as well as for knee/hip replacement, reveal some encouraging news. In clinical trials, bDMARDs have been shown to increase the risk of…

Filed under:ConditionsResearch RheumRheumatoid Arthritis Tagged with:Association of Rheumatology Professionals (ARP)bDMARDbenefitsbiologic disease-modifying antirheumatic drugsCardiovascular diseaseClinicalhipkneeoutcomepatient carereplacementResearchRheumatoid arthritisrheumatologistrheumatologyriskstudytherapy

2017 ACR/ARHP Award Winners Advance Rheumatology, Part 1

Richard Quinn  |  December 17, 2017

SAN DIEGO—At the 2017 ACR/ARHP Annual Meeting in San Diego last month, the ACR and the ARHP honored a group of distinguished individuals who have made significant contributions to rheumatology research, education and patient care. This month, The Rheumatologist speaks with the ACR winners about their individual contributions to advancing rheumatology. In coming issues, we…

Filed under:AwardsCareer DevelopmentMeeting ReportsProfessional Topics Tagged with:AC&RACR MastersACR/ARHP Annual MeetingAmerican College of Rheumatology (ACR)Association of Rheumatology Professionals (ARP)AwardsDistinguished Clinical InvestigatorfellowshipHenry Kunkel Young Investigator AwardhonorsinvestigatorPaulding Phelps AwardPresidential Gold Medalwinners

Opioid Painkiller Prescriptions May Run in Families

Lisa Rapaport  |  December 12, 2017

(Reuters Health)—When one person in a household gets prescribed opioids, the other people who live with them are more likely to get their own prescriptions for these narcotic painkillers, a U.S. study suggests. Researchers examined data on about 12.6 million people living in a household where someone was prescribed opioids and 6.4 million individuals in…

Filed under:AnalgesicsDrug Updates Tagged with:familyOpioid abuseopioid painkillersOpioids

Biosimilars Great Debate: To Switch or Not?

Susan Bernstein  |  November 17, 2017

SAN DIEGO—Should patients with rheumatic diseases switch from a biologic to its biosimilar? At the 2017 ACR/ARHP Annual Meeting’s Great Debate, held Nov. 5, two rheumatologists argued whether to switch or stay put based on safety, efficacy and potential cost savings. First to the podium to make the case for switching, Jonathan Kay, MD, tweaked…

Filed under:Biologics/DMARDsEducation & TrainingMeeting Reports Tagged with:2017 ACR/ARHP Annual MeetingBiologicsBiosimilarsJonathan KayRheumatic DiseaseRoy Fleischmann

Lower Medicaid Fees Linked to Scarcer Primary Care Appointments

Cheryl Platzman Weinstock  |  November 16, 2017

(Reuters Health)—When the fees paid to healthcare providers by Medicaid go up, appointments with primary care doctors suddenly become more available to Medicaid beneficiaries – and the opposite happens when fees go down, according to a recent U.S. study. Researchers found that, overall, every $10 change up or down in the Medicaid fees paid to…

Filed under:Practice SupportProfessional Topics Tagged with:lower Medicaid feesMedicaid funding reductionsprimary care appointmentsU.S. study

Consumers Sign Up for Obamacare 2018 Individual Plans Despite Uncertainty

Reuters Staff  |  November 9, 2017

NEW YORK (Reuters)— Consumer sign-ups for Obamacare individual insurance plans were more than 600,000 during the first week of enrollment for 2018, a U.S. health agency said on Thursday, a positive sign for insurers who take part in the healthcare program that Republicans are trying to undo. The Centers for Medicare & Medicaid Services, a…

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:consumer sign-upsObamacare 2018 individual plans

  • « Previous Page
  • 1
  • …
  • 85
  • 86
  • 87
  • 88
  • 89
  • …
  • 118
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences